Analysis of Orthopedic Patients Response to New Pain Modulating Substances and Drugs

Effect of New Pain Modulating Substances in Orthopedics

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03138460

Enrollment

100

Registered

2017-05-03

Start date

2015-01-01

Completion date

2018-08-01

Last updated

2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

Data of patient reported outcomes (PRO) are collected during treatment with various pain alleviation methods (drugs or substances)

Detailed description

The study aims at collecting BPI (brief pain inventory) and other PRO of patients in need of pain relief due to chronic orthopedic pain conditions

Interventions

OTHERstandard medications crossed over to cannabis

Study design

Observational model

CASE_CROSSOVER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Chronic pain of orthopedic origin treated for at least one year unsuccessfully

Exclusion criteria

contra-indication for cannabis treatment

Design outcomes

Primary

Measure	Time frame	Description
Brief pain inventory score (BPI)	2 years	score of PRO

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026